Raphael Pharmaceutical Stock Investor Sentiment

RAPH Stock   0.26  0.00  0.00%   
Under 61% of Raphael Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Raphael Pharmaceutical suggests that many traders are alarmed regarding Raphael Pharmaceutical's prospects. Raphael Pharmaceutical's investing sentiment shows overall attitude of investors towards Raphael Pharmaceutical.
  
over three weeks ago at news.google.com         
Raphael Pharmaceutical Inc Quarterly 10-Q Report - Quartzy
Google News at Macroaxis
over two months ago at news.google.com         
Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling - Cannabis Business T...
Google News at Macroaxis
over two months ago at news.google.com         
Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Cultivation - Cannabis ...
Google News at Macroaxis
over three months ago at news.google.com         
On Our Radar Applications open for leadership academy, plus a recap of Warnocks visit - AOL
Google News at Macroaxis
over three months ago at news.google.com         
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market - Reuters
Google News at Macroaxis
over three months ago at news.google.com         
Raphael Pharmaceutical Issues Letter to Shareholders - StockTitan
Google News at Macroaxis
over six months ago at news.google.com         
Sen. Raphael Warnock proposes slashing gas, drug, and shipping costs to beat inflation ahead of a mi...
Google News at Macroaxis
over six months ago at news.google.com         
Raphael Pharmaceutical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 - Mar...
Google News at Macroaxis
over six months ago at news.google.com         
Watch Bloomberg Markets With Sonali Basak 02282024 - Bloomberg
Google News at Macroaxis
over six months ago at news.google.com         
Pharmacies across US disrupted following hack at Change Healthcare network - Reuters
Google News at Macroaxis
over six months ago at news.google.com         
Stocks of Covid antiviral drug Paxlovid run dry amid fifth wave - New Zealand Herald
Google News at Macroaxis
over a year ago at news.google.com         
Health Experts Raise Alarm Call For Strict Law Enforcement - Peace FM Online
Google News at Macroaxis
over a year ago at news.google.com         
Stock market news today Stocks rise slightly after huge week of gains - AOL
Google News at Macroaxis
over a year ago at news.google.com         
Feds Bostic possible Fed could lower rates in late 2024 - CNBC - Reuters
Google News at Macroaxis
over a year ago at news.google.com         
Far More Potent Than THC And CBD Dr. Raphael Mechoulam Explains His Latest Discovery - Benzinga
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Raphael Pharmaceutical that are available to investors today. That information is available publicly through Raphael media outlets and privately through word of mouth or via Raphael internal channels. However, regardless of the origin, that massive amount of Raphael data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Raphael Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Raphael Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Raphael Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Raphael Pharmaceutical alpha.

Raphael Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Raphael OTC Stock analysis

When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments